SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
DocGo Inc. (DCGO) has a negative trailing P/E of -0.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -333.04%.
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+178.5%).
- Trailing Earnings Yield -333.04% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
- Analyst consensus target $1.50 (+178.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DCGO
Valuation Multiples
P/E (TTM)-0.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.38
P/S Ratio0.17
EV/EBITDA-0.5
Per Share Data
EPS (TTM)$-1.86
Book Value / Share$1.28
Revenue / Share$3.29
FCF / Share$0.28
Yields & Fair Value
Earnings Yield-333.04%
Dividend Yield0.00%
SharesGrow IV$356,478,000.00 (+66186037776%)
Analyst Target$1.50 (+178.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-51.1 |
0.00 |
15.08 |
21.37 |
- |
| 2020 |
-70.8 |
2.36 |
18.50 |
10.81 |
- |
| 2021 |
31.6 |
-0.10 |
3.42 |
2.36 |
- |
| 2022 |
20.7 |
1.55 |
2.62 |
1.62 |
- |
| 2023 |
84.4 |
-1.05 |
1.92 |
0.93 |
- |
| 2024 |
21.7 |
0.11 |
1.35 |
0.70 |
298,147.16% |
| 2025 |
-0.5 |
0.00 |
0.60 |
0.27 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.21 |
$48.3M |
$-21.24M |
-44% |
| 2020 |
$-0.25 |
$94.09M |
$-14.8M |
-15.7% |
| 2021 |
$0.25 |
$318.72M |
$23.74M |
7.4% |
| 2022 |
$0.34 |
$440.52M |
$34.58M |
7.9% |
| 2023 |
$0.06 |
$624.29M |
$6.86M |
1.1% |
| 2024 |
$0.18 |
$616.56M |
$19.99M |
3.2% |
| 2025 |
$-1.84 |
$322.2M |
$-182.4M |
-56.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-0.32 |
$-2.01 – $1.27 |
$298.91M |
$298.11M – $299.72M |
3 |
| 2027 |
$-0.19 |
$-0.38 – $-0.01 |
$319.1M |
$314.29M – $323.9M |
2 |
